Related Experiment Video
Updated: Aug 11, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation
Published on: September 4, 2017
Risk estimation for carcinogens based on epidemiological data: a structured approach, illustrated by an example on
R Alexandra Goldbohm1, Erik L J P Tielemans, Dick Heederik
1TNO Quality of Life, Business Unit Food & Chemical Risk Analysis, Zeist, The Netherlands. bausch@voeding.tno.nl
This study presents a framework for quantitative cancer risk assessment using human epidemiological data. It offers a structured, transparent approach for reliable risk estimation, prioritizing human evidence over animal studies.
Area of Science:
- Environmental Health
- Toxicology
- Epidemiology
Background:
- Human epidemiological data are preferred for quantitative risk analysis over animal studies.
- Existing methods for epidemiological risk assessment face challenges due to unfamiliarity and lack of structured approaches.
Purpose of the Study:
- To describe a framework for conducting quantitative cancer risk assessment using epidemiological studies.
- To ensure a structured, transparent, and reproducible approach to risk assessment.
Main Methods:
- Utilized a weight-of-the-evidence approach.
- Estimated optimal exposure-risk functions via regression modeling of epidemiological data.
- Quantified uncertainty from biases and missing data.
- Calculated excess lifetime risk using life tables to account for competing risks.
- Employed sensitivity analyses to assess the impact of assumptions and data variability.
Main Results:
- Developed a flexible framework applicable to various data types, from published to individual data.
- The framework facilitates state-of-the-art risk estimation with confidence intervals.
- Incorporates methods to handle potential biases and missing information in epidemiological studies.
Conclusions:
- The proposed framework enhances the reliability and transparency of quantitative cancer risk assessment from epidemiological data.
- It provides a robust method for estimating cancer risks by integrating diverse evidence and accounting for uncertainties.
- This approach supports evidence-based decision-making in public health and environmental regulation.
Related Concept Videos
Mutagenicity and Carcinogenicity
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Statistical Methods for Analyzing Epidemiological Data
Hazard Ratio
For example, in a clinical trial evaluating a...
Cancer Prevention
Some...
Relative Risk
